186 related articles for article (PubMed ID: 19998348)
1. Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.
Shuch B; Said J; LaRochelle JC; Zhou Y; Li G; Klatte T; Pouliot F; Kabbinavar FF; Belldegrun AS; Pantuck AJ
Cancer; 2010 Feb; 116(3):616-24. PubMed ID: 19998348
[TBL] [Abstract][Full Text] [Related]
2. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?
Shuch B; Said J; La Rochelle JC; Zhou Y; Li G; Klatte T; Kabbinaavar FF; Pantuck AJ; Belldegrun AS
J Urol; 2009 Nov; 182(5):2164-71. PubMed ID: 19758641
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
Cheville JC; Lohse CM; Zincke H; Weaver AL; Leibovich BC; Frank I; Blute ML
Am J Surg Pathol; 2004 Apr; 28(4):435-41. PubMed ID: 15087662
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid renal cell carcinoma with foci of chromophobe carcinoma.
Cserni G; Kovács BR; Tarján M; Sápi Z; Domján Z; Szabó Z
Pathol Oncol Res; 2002; 8(2):142-4. PubMed ID: 12172580
[TBL] [Abstract][Full Text] [Related]
10. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
11. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
Adibi M; Thomas AZ; Borregales LD; Merrill MM; Slack RS; Chen HC; Sircar K; Murugan P; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
Urol Oncol; 2015 Oct; 33(10):427.e17-23. PubMed ID: 26004164
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
Keskin SK; Msaouel P; Hess KR; Yu KJ; Matin SF; Sircar K; Tamboli P; Jonasch E; Wood CG; Karam JA; Tannir NM
J Urol; 2017 Sep; 198(3):530-537. PubMed ID: 28411072
[TBL] [Abstract][Full Text] [Related]
13. Percentage of sarcomatoid histology is associated with survival in renal cell carcinoma: Stratification and implications by clinical metastatic stage.
Patel HD; Man A; Koehne EL; Rac G; Aragao AP; Flanigan RC; Gorbonos A; Gupta GN; Woods ME; Picken MM; Quek ML
Urol Oncol; 2022 Jul; 40(7):347.e1-347.e8. PubMed ID: 35551862
[TBL] [Abstract][Full Text] [Related]
14. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
15. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
16. Chromophobe renal cell carcinoma with sarcomatoid change. A case report.
Nagashima Y; Okudela K; Osawa A; Nakamura N; Kawasaki C; Moriyama M; Nakamura N; Nakatani Y; Kitamura H; Aoki I
Pathol Res Pract; 2000; 196(9):647-51; discussion 652. PubMed ID: 10997740
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma.
Brunelli M; Gobbo S; Cossu-Rocca P; Cheng L; Hes O; Delahunt B; Pea M; Bonetti F; Mina MM; Ficarra V; Chilosi M; Eble JN; Menestrina F; Martignoni G
Mod Pathol; 2007 Mar; 20(3):303-9. PubMed ID: 17277768
[TBL] [Abstract][Full Text] [Related]
18. Concordance of Pathologic Features Between Metastatic Sites and the Primary Tumor in Surgically Resected Metastatic Renal Cell Carcinoma.
Psutka SP; Cheville JC; Costello BA; Stewart-Merrill SB; Lohse CM; Leibovich BC; Boorjian SA; Thompson RH
Urology; 2016 Oct; 96():106-113. PubMed ID: 27453217
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid renal tumors. Clinicopathologic correlation of three cases.
Bonsib SM; Fischer J; Plattner S; Fallon B
Cancer; 1987 Feb; 59(3):527-32. PubMed ID: 3791161
[TBL] [Abstract][Full Text] [Related]
20. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
